The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Open accessAbstract
Antibodies to the prefusion conformation of the RSV F glycoprotein neutralize natural infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226
Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus
Glezen, W. P. (1986) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1986.02140200053026 · Cited by 1,527
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126
Self-citationStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Self-citationRates of hospitalization for respiratory syncytial virus infection among children in Medicaid
Boyce, T. G., Mellen, B. G., Mitchel, E. F., Wright, P. F., & Griffin, M. R. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.110531 · Cited by 688
Zhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L., & Pickles, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5654-5666.2002 · Cited by 581
Self-citationMcLellan, J. S., Yang, Y., Graham, B. S., & Kwong, P. D. (2011) · Journal of Virology · doi:10.1128/jvi.00555-11 · Cited by 436
Self-citationPrimary respiratory syncytial virus infection in mice
Graham, B. S., Perkins, M. D., Wright, P. F., & Karzon, D. T. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260207 · Cited by 393
Self-citationGlycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection
Hallak, L. K., Spillmann, D., Collins, P. L., & Peeples, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10508-10513.2000 · Cited by 311
Self-citationZhang, L., Bukreyev, A., Thompson, C. I., Watson, B., Peeples, M. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1113-1124.2005 · Cited by 302 · cited 1×
“RSVusesheparan sulfate as its receptor in immortalized cells (22), but HAE cultures, which display tight junctions, do not display detectable amounts of heparan sulfate on their apical surface where infection is initiated (23).”
BackgroundSelf-citationKwakkenbos, M. J., Diehl, S. A., Yasuda, E., Bakker, A. Q., van Geelen, C. M. M., Lukens, M. V., van Bleek, G. M., Widjojoatmodjo, M. N., Bogers, W. M. J. M., Mei, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2071 · Cited by 300
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Corti, D., Bianchi, S., Vanzetta, F., Minola, A., Perez, L., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 278
Magro, M., Mas, V., Chappell, K., Vázquez, M., Cano, O., Luque, D., Terrón, M. C., Melero, J. A., & Palomo, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115941109 · Cited by 271 · cited 2×
“An earlier study showed that in high-titer pooled human immunoglobulin, NT activity could not be removed with post-F, suggesting that pre-F–specific antibodies may be important in RSV neutralization (17).”
BackgroundStructural basis of respiratory syncytial virus neutralization by motavizumab
McLellan, J. S., Chen, M., Kim, A., Yang, Y., Graham, B. S., & Kwong, P. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1723 · Cited by 182
Self-citationGilman, M. S. A., Moin, S. M., Más, V., Chen, M., Patel, N., Kari, K., Zhu, Q., Kabeche, S. C., Kumar, A., Palomo, C., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005035 · Cited by 161
Self-citationHotard, A. L., Shaikh, F. Y., Lee, S., Yan, D., Teng, M. N., Plemper, R. K., Crowe, J. E., & Moore, M. L. (2012) · Virology · doi:10.1016/j.virol.2012.09.022 · Cited by 158
Cherukuri, A., Patton, K., Gasser, R. A., Zuo, F., Woo, J. C., Esser, M. T., & Tang, R. S. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00580-12 · Cited by 122
Calder, L. J., González-Reyes, L., García‐Barreno, B., Wharton, S. A., Skehel, J. J., Wiley, D. C., & Melero, J. A. (2000) · Virology · doi:10.1006/viro.2000.0279 · Cited by 109
McLellan, J. S., Correia, B. E., Chen, M., Yang, Y., Graham, B. S., Schief, W. R., & Kwong, P. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.044 · Cited by 105
Self-citationComputational prediction of N-linked glycosylation incorporating structural properties and patterns
Chuang, G., Boyington, J. C., Joyce, M. G., Zhu, J., Nabel, G. J., Kwong, P. D., & Georgiev, I. S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts426 · Cited by 97
Self-citationInfluence of Respiratory Syncytial Virus Strain Differences on Pathogenesis and Immunity
Melero, J. A., & Moore, M. L. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-38919-1_3 · Cited by 74
Magro, M., Andreu, D., Gómez‐Puertas, P., Melero, J. A., & Palomo, C. (2010) · Journal of Virology · doi:10.1128/jvi.00447-10 · Cited by 59
Respiratory syncytial virus vaccine development
Anderson, L. J. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.011 · Cited by 56
Role of complement in neutralization of respiratory syncytial virus
Yoder, S. M., Zhu, Y., Ikizler, M. R., & Wright, P. F. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20046 · Cited by 31
Cited by
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Walsh, E. E., Pérez Marc, G., Zareba, A. M., Falsey, A. R., Jiang, Q., Patton, M., Polack, F. P., Llapur, C., Doreski, P. A., Ilangovan, K., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213836 · Cited by 668
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Wilson, E., Goswami, J., Baqui, A. H., Doreski, P. A., Perez-Marc, G., Zaman, K., Monroy, J., Duncan, C. J. A., Ujiie, M., Rämet, M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307079 · Cited by 500
Mazur, N. I., Higgins, D., Nunes, M. C., Melero, J. A., Langedijk, A. C., Horsley, N., Buchholz, U. J., Openshaw, P. J., McLellan, J. S., Englund, J. A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30292-5 · Cited by 457
Self-citationMarcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E., Benhaim, M., Ravichandran, R., Carter, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 448
Metadata
- Authors
- Ngwuta, J. O., Chen, M., Modjarrad, K., Joyce, M. G., Kanekiyo, M., Kumar, A., Yassine, H. M., Moin, S. M., Killikelly, A. M., Chuang, G.-Y., Druz, A., Georgiev, I. S., Rundlet, E. J., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Nason, M. C., Capella, C., Peeples, M. E., Ledgerwood, J. E., McLellan, J. S., Kwong, P. D., & Graham, B. S.
- Venue
- Science Translational Medicine
- Published
- 2015-10-14
- Volume
- 7
- Issue
- 309
- Pages
- 309ra162-309ra162
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2270869679
- Cited by
- 431
- References
- 26
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.